Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

MNPR

Monopar Therapeutics Inc.

Healthcare · USD

Set alert

Price alert · MNPR

All alert types
70.32 USD -1.59 -2.21%
As of Oct 30, 2026 Extended hours 70.32 0.00%
Bid
70.33 × 2
Ask
70.58 × 5
69.35 Day range 72.76
50.12 52-week range 123.84
YTD
+7.69%
1 year
-17.92%
Open
71.36
Prev close
71.91
Mkt cap
472.00M
Vol
197.76K
Avg vol
175.31K
EPS
-2.20
P/E
0.00
Div yield
0.00%
More statistics
Low
69.35
High
72.76
Forward P/E
-10.17
Beta
1.10
Short ratio
0.15
Inst. own
24.47%
Dividend
0.00
Ex-div date
Earnings
Aug 9, 2024
50-d avg
17.85
200-d avg
7.12
1y target
27.33

5D chart

Chart tools
Interval
1m5m15m30m
MNPR five-day price chart69.370.872.373.875.3Oct 23Oct 26Oct 27Oct 28Oct 29

Financial health

Altman Z-Score

68.36 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

0 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -35.3×
FY 2016: -1104×FY 2017: -83.3×FY 2018: -427×FY 2019: -208×FY 2020: -52.8×FY 2021: -22.0×FY 2022: -14.3×FY 2023: -2.9×FY 2024: -16.2×FY 2025: -35.3×
FY 2016 5y median -16.2× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 3.5×
FY 2016: 461×FY 2017: 144×FY 2018: 200×FY 2019: 69.6×FY 2020: 21.4×FY 2021: 10.6×FY 2022: 14.9×FY 2023: 4.4×FY 2024: 4.6×FY 2025: 3.5×
FY 2016 5y median 4.6× FY 2025
P/FCF -39.7×
FY 2016: -1093×FY 2017: -526×FY 2018: -478×FY 2019: -291×FY 2020: -71.9×FY 2021: -27.4×FY 2022: -20.8×FY 2023: -3.1×FY 2024: -39.3×FY 2025: -39.7×
FY 2016 5y median -27.4× FY 2025
EV/EBITDA -30.8×
FY 2016: 162315×FY 2017: -94.9×FY 2018: 9346189×FY 2019: -205×FY 2020: 0.0×FY 2021: -19.8×FY 2022: -13.6×FY 2023: -2.1×FY 2024: -13.2×FY 2025: -30.8×
FY 2016 5y median -13.6× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -2.5%
FY 2016: -0.1%FY 2017: -0.2%FY 2018: -0.2%FY 2019: -0.3%FY 2020: -1.4%FY 2021: -3.7%FY 2022: -4.8%FY 2023: -31.9%FY 2024: -2.5%FY 2025: -2.5%
FY 2016 5y median -3.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -10.0%
FY 2016: -41.9%FY 2017: -172.1%FY 2018: -46.7%FY 2019: -33.5%FY 2020: -40.2%FY 2021: -48.1%FY 2022: -104.2%FY 2023: -150.4%FY 2024: -28.3%FY 2025: -10.0%
FY 2016 5y median -48.1% FY 2025
ROIC -12.1%
FY 2016: -42.1%FY 2017: -172.6%FY 2018: -45.4%FY 2019: -34.2%FY 2020: -41.5%FY 2021: -48.2%FY 2022: -104.3%FY 2023: -158.0%FY 2024: -29.4%FY 2025: -12.1%
FY 2016 5y median -48.2% FY 2025
ROA -9.7%
FY 2016: -40.9%FY 2017: -166.7%FY 2018: -44.1%FY 2019: -31.6%FY 2020: -37.4%FY 2021: -44.4%FY 2022: -79.5%FY 2023: -114.4%FY 2024: -25.9%FY 2025: -9.7%
FY 2016 5y median -44.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -3.4%
FY 2016: -73.1%FY 2017: -1291.9%FY 2018: 79.5%FY 2019: -27.1%FY 2020: -50.5%FY 2021: -40.2%FY 2022: -15.4%FY 2023: 16.2%FY 2024: -83.0%FY 2025: -3.4%
FY 2016 FY 2025
EPS (diluted) -36.0%
FY 2016: -42.5%FY 2017: -1225.0%FY 2018: 80.5%FY 2019: -29.0%FY 2020: -45.0%FY 2021: -25.9%FY 2022: -13.7%FY 2023: 30.1%FY 2024: -134.5%FY 2025: -36.0%
FY 2016 FY 2025
Free Cash Flow -90.5%
FY 2016: -87.7%FY 2017: -119.9%FY 2018: -9.9%FY 2019: -4.5%FY 2020: -54.5%FY 2021: -56.9%FY 2022: 1.2%FY 2023: -8.7%FY 2024: 18.5%FY 2025: -90.5%
FY 2016 FY 2025

Financial Health

Current Ratio 51.4×
FY 2016: 32.5×FY 2017: 29.3×FY 2018: 18.3×FY 2019: 18.3×FY 2020: 14.3×FY 2021: 13.0×FY 2022: 4.2×FY 2023: 4.2×FY 2024: 11.5×FY 2025: 51.4×
FY 2016 5y median 11.5× FY 2025
Quick Ratio 51.4×
FY 2016: 32.5×FY 2017: 29.3×FY 2018: 18.3×FY 2019: 18.3×FY 2020: 14.3×FY 2021: 13.0×FY 2022: 4.2×FY 2023: 4.2×FY 2024: 11.5×FY 2025: 51.4×
FY 2016 5y median 11.5× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 4.5×
FY 2016: -258×FY 2017: 0.6×FY 2018: -46890×FY 2019: 3.1×FY 2020: 0.0×FY 2021: 2.2×FY 2022: 0.8×FY 2023: 0.9×FY 2024: 2.9×FY 2025: 4.5×
FY 2016 5y median 2.2× FY 2025
Interest Coverage 0.0×
FY 2016: -165×FY 2017: -344×FY 2018: -33.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31